Competition | Regulation | Litigation
Blogs
26-08-2022
Mergers and acquisitions reviewable in new ways: will healthcare be an exception?
New paths to a filing and key changes in healthcare merger review. Read more >
14-07-2022
Five tips for information exchange in due diligence investigations and M&A transactions. What is and is not allowed under the cartel prohibition?
The exchange of information between companies as part of a merger or acquisition may be prohibited. This blog summarises the main points for attention. Read more >
28-06-2022
Adjustments to NZa merger test: more limited scope but more intensive review
The NZa will change its healthcare-specific merger test as of 1 July 2022 on three points. The changes are addressed in this blog. Read more >
22-06-2022
ACM and European Commission step up action against abuse of dominant position of pharmaceutical companies
ACM and the European Commission are focusing their attention on abuse of a dominant position in the pharmaceutical sector. This blog lists the lessons that pharmaceutical companies can learn from the supervision by ACM and the Commission. Read more >
20-06-2022
Buma/Stemra abuses dominant position and must pay damages
Court of Appeal rules that Buma/Stemra abused its dominant position in relation to suppliers of background music by applying unequal conditions to streaming services. Read more in this blog. Read more >
25-05-2022
Sustainability of the agri-food supply chain and market power of retailers: an unhappy marriage. Does competition law offer a solution?
This blog concerns the Unfair Practices Act an de prohibition of abuse of dominance. It also addresses producer organisations, sustainability initiatives and below-cost sales. Read more >
18-05-2022
Implementation of the Investments Screening Bill: vigilance already required
The Wet veiligheidstoets investeringen, fusies en overnames (Investments Screening Bill – "ISB") introduces a test for investments in vital providers and sensitive technologies. This blog addresses the scope of application and the main points for attention of the ISB. Read more >